It is a chemicals private limited company based in Thane, Maharashtra, India, established in 1992.
1992 | Thane, Maharashtra, India | AmalgamatedApostolos Pharmaceuticals Pvt Ltd, a amalgamated private limited company, was established on 12 February 1992 in Thane, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239MH1992PTC065391. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Geeta Ashok Bhave (Director), Ravi Chettuvatty Menon (Director), Siddesh Niranjan Sigtia (Additional Director). Past directors included Ravi Chettuvatty Menon, Loknath Nemu Anchan, Indra Durlabhji. Its latest AGM occurred on 26 September 2017, with the balance sheet filed on 31 March 2017. It is based at Plot No R-239 T T C Industrial Area M I D C, Rabale,Thane Belapur Road, Thane, Maharashtra, 400701.
U24239MH1992PTC065391
065391
12 February 1992
₹2.50 M
₹0.10 M
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Apostolos Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geeta Ashok Bhave | Director | 27 Jan 2004 | Current |
| Ravi Chettuvatty Menon | Director | 09 Sep 2008 | Current |
| Siddesh Niranjan Sigtia | Additional Director | 04 Sep 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2016 | Past |
| Pramod Abcsdd | Alternate Director | 01 Mar 2010 | Past |
| Pramod Abcsdd | Director | 31 Oct 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apostolos Pharmaceuticals Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Apostolos Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Apostolos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Apostolos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apostolos Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Apostolos Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 26 Sep 2017 as per latest MCA records. was documented.
The activity Siddesh Niranjan Sigtia was appointed as a Additional Director was appointed as a Additional Director on 04 Sep 2017 & has been associated with this company since 8 years 2 months . was completed.
Progress on Apostolos Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was documented.
Progress on Ravi Chettuvatty Menon was appointed as a Director was appointed as a Director on 09 Sep 2008 & has been associated with this company since 17 years 2 months . was documented.
The activity Geeta Ashok Bhave was appointed as a Director was appointed as a Director on 27 Jan 2004 & has been associated with this company since 21 years 10 months . was completed.
The activity Apostolos Pharmaceuticals Pvt Ltd was registered on 12 Feb 1992 with Roc Mumbai & aged 33 years 9 months as per MCA records. was completed.
The CIN of Apostolos Pharmaceuticals Pvt Ltd is U24239MH1992PTC065391.
Apostolos Pharmaceuticals Pvt Ltd is headquartered at Plot No R-239 T T C Industrial Area M I D C, Rabale,Thane Belapur Road, Thane, Maharashtra, 400701.
Apostolos Pharmaceuticals Pvt Ltd was incorporated on 12 February 1992.
The current directors of Apostolos Pharmaceuticals Pvt Ltd are
The primary industry of Apostolos Pharmaceuticals Pvt Ltd is Chemicals.
Apostolos Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Apostolos Pharmaceuticals Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX